Article
Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.
Gynecologic oncology - 1 Mar 2012
Bodelon Clara, Madeleine Margaret M, Johnson Lisa G, Du Qin, Malkki Mari, Petersdorf Effie W, Schwartz Stephen M
Abstract excerpt
OBJECTIVES: The CD83 glycoprotein is a marker of dendritic cell maturation that may contribute to the T cell response to oncogenic human papillomavirus (HPV) infection. Whether single nucleotide polymorphisms (SNPs) in CD83 influence the risk of HPV-related genital cancers has not been adequately studied. We investigated whether the common genetic variation of the CD83 region was associated with the risks of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.